Company research
BRAIN SCIENTIFIC INC.
CIK 1662382Updated Sep 29, 2026
SecurityBRSF · OTC · equity
Name history
All Soft Gels Inc · through Sep 24, 2018
BRSF price & chart
Loading TradingView…
OTC:BRSF on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 11,743,625Source | 13,375,216Source | 440,218Source | 291,002Source |
| Property, Plant and Equipment, NetUSD | 120,914Source | 122,979Source | 302Source | 1,674Source |
| GoodwillUSD | — | 913,184Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 10,151,172Source | 10,920,577Source | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 747,714Source | 785,363Source | 272,856Source | 261,436Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 947Source | 16,922Source | 1,460Source | 5,555Source |
| Inventory, NetUSD | 149,558Source | 146,090Source | 1,461Source | — |
| Assets, CurrentUSD | 1,308,002Source | 1,131,774Source | 439,916Source | 289,328Source |
| Prepaid Expense and Other Assets, CurrentUSD | 30,537Source | 46,170Source | 93,807Source | 21,637Source |
| Operating Lease, Right-of-Use AssetUSD | 88,537Source | 191,702Source | 69,632Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,426,403Source | 14,070,149Source | 5,237,042Source | 1,186,534Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 1,243Source | 50,217Source | 19,628Source | 19,381Source |
| Additional Paid in CapitalUSD | 38,942,765Source | 21,537,763Source | 3,144,490Source | 2,756,798Source |
| Retained Earnings (Accumulated Deficit)USD | -34,622,781Source | -22,278,923Source | -7,956,862Source | -3,672,077Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -4,005Source | -3,990Source | -4,080Source | 366Source |
| Stockholders' Equity Attributable to ParentUSD | 4,317,222Source | -694,933Source | -4,796,824Source | -895,532Source |
| Liabilities and EquityUSD | 11,743,625Source | 13,375,216Source | 440,218Source | 291,002Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,419,025Source | 4,006,509Source | 5,205,766Source | 1,186,534Source |
| Operating Lease, Liability, CurrentUSD | 83,710Source | 104,591Source | 41,793Source | — |
| Operating Lease, Liability, NoncurrentUSD | 7,378Source | 91,089Source | 31,276Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 2,512,622Source | 2,987,264Source | — | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | -9,100,686Source | 4,284,785Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | 1,330Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 30,207Source | 12,797Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -15,975Source | 1,570Source | -4,095Source | 5,555Source |
| Increase (Decrease) in InventoriesUSD | 3,468Source | 99,372Source | 1,461Source | 7,085Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | 159,441Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -5,935,070Source | -5,866,792Source | -1,173,409Source | -854,726Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -33,293Source | -58,647Source | — | -1,005Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 33,293Source | 58,647Source | — | 1,005Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 5,930,621Source | 6,645,849Source | 1,189,367Source | 953,238Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -37,649Source | 716,420Source | 11,420Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 747,714Source | 785,363Source | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 148,169Source | 72,000Source | 9,867Source | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 93Source | -3,990Source | — | — |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 2,760,515Source | 89,787Source | — | — |
| Amortization of Intangible AssetsUSD | 20,000Source | — | — | — |
| AssetAcquisitionContingentConsiderationLiabilityUSD | 10,832,685Source | — | — | — |
| DepreciationUSD | 804,763Source | 219,833Source | 1,372Source | 1,330Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 1,573,792Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 962Source | -21Source | 23Source | -52Source |
| Gain (Loss) on Extinguishment of DebtUSD | 201,097Source | — | -294,301Source | — |
| General and Administrative ExpenseUSD | 4,468,828Source | 3,326,306Source | 930,138Source | 532,312Source |
| GoodwillUSD | — | 913,184Source | — | — |
| Goodwill and Intangible Asset ImpairmentUSD | 913,184Source | — | — | — |
| Goodwill, Impairment LossUSD | 913,184Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | 2,214Source |
| Net Income (Loss) Attributable to ParentUSD | -12,343,858Source | -9,100,686Source | -4,284,785Source | -1,003,865Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | -3,575,585Source | — | — |
| Nonoperating Income (Expense)USD | -2,735,451Source | -444,209Source | -2,451,589Source | -31,463Source |
| Operating ExpensesUSD | 9,662,732Source | 8,739,705Source | 1,968,169Source | 1,072,196Source |
| Proceeds from Contributed CapitalUSD | — | — | — | 154Source |
| Unrealized Gain (Loss) on DerivativesUSD | 201,097Source | — | — | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Total RevenueUSD | 214,564Source | 265,747Source | 544,275Source | 489,202Source |
| Cost of RevenueUSD | 160,239Source | 182,519Source | 409,302Source | 387,194Source |
| Operating Income (Loss)USD | -9,608,407Source | -8,656,477Source | -1,833,196Source | -970,188Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -12,343,858Source | -9,100,686Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | 2,214Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | -3,575,585Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -12,343,858Source | -9,100,686Source | -4,284,785Source | -1,003,865Source |
| Earnings Per Share, BasicUSD per share | -12.95Source | -0.26Source | — | — |
| Earnings Per Share, DilutedUSD per share | -12.95Source | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 953,272Source | 30,680,204Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 953,272Source | — | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 20,000Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 1,372Source | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 962Source | -21Source | 23Source | -52Source |
| General and Administrative ExpenseUSD | 4,468,828Source | 3,326,306Source | 930,138Source | 532,312Source |
| Goodwill, Impairment LossUSD | 913,184Source | — | — | — |
| Gross ProfitUSD | 54,325Source | 83,228Source | 134,973Source | 102,008Source |
| Interest ExpenseUSD | 844,855Source | 467,849Source | 6,996Source | 32,922Source |
| Marketing and Advertising ExpenseUSD | 696,958Source | 1,041,575Source | 244,774Source | — |
| Nonoperating Income (Expense)USD | -2,735,451Source | -444,209Source | -2,451,589Source | -31,463Source |
| Operating ExpensesUSD | 9,662,732Source | 8,739,705Source | 1,968,169Source | 1,072,196Source |
| Other ExpensesUSD | — | — | — | 597Source |
| Other IncomeUSD | 7,252Source | 1,110Source | 8,260Source | 2,108Source |
| Research and Development ExpenseUSD | 301,907Source | 329,452Source | 275,926Source | 103,616Source |
| Selling and Marketing ExpenseUSD | 696,958Source | 1,041,575Source | 244,774Source | 95,165Source |